Your session is about to expire
← Back to Search
Preoperative Chemotherapy for Retroperitoneal Sarcoma(STRASS2 Trial)
STRASS2 Trial Summary
This trialtests if chemo before surgery can help people with a certain type of cancer live longer.
- Retroperitoneal Sarcoma
STRASS2 Trial Eligibility Criteria
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
STRASS2 Trial Timeline
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
STRASS2 Trial Design
Find a Location
Who is running the clinical trial?
- You have certain types of sarcoma that originated from bone, abdominal or gynecological organs, and it has spread to other parts of the body. You have a history of severe allergic reactions to certain medications used to treat sarcoma. You have experienced long-term suppression of your bone marrow. You have had a heart attack within the past 6 months. You have uncontrolled heart rhythm problems. You have already received the maximum allowed doses of certain chemotherapy drugs. You have active and uncontrolled infections. You have received live vaccines within the past month. You have bladder inflammation or blockage of urine flow. You have had another type of cancer within the past 5 years, except for certain types of skin, cervical, or prostate cancer that have been treated and cured. You have uncontrolled severe illness or medical conditions other than the specific type of sarcoma being studied. If you are a female patient, you are pregnant or breastfeeding, or if you are a male or female patient capable of having children, you are not willing to use effective birth control methods. You have any psychological, family, social, or geographical circumstances that could make it difficult for you to follow the study's instructions and schedule. You have known allergies to certain imaging agents and magnetic resonance imaging (MRI).
- Group 1: Standard arm
- Group 2: Experimental arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there opportunities for participators still available in this experiment?
"Indeed, the information on clinicaltrials.gov confirms that this trial is open and accepting participants. This research project was initially posted on January 20th 2021 and last updated on December 27th 2022; 250 volunteers are needed from two separate sites."
How many participants are accepted into the clinical trial at this time?
"Affirmative. Clinicaltrials.gov data shows that this investigation, which was initially announced on January 20th 2021, is still recruiting individuals to participate. The clinical trial requires 250 participants from two medical centres."
To what degree is the Experimental arm safe for human use?
"Our team has rated the safety of Experimental arm at a 3, indicating that there is existing clinical data substantiating its efficacy along with numerous reports validating its security."
Share this study with friends